SHROOM3: A Potential Drug Target and Biomarker (G57619)

Target Name: SHROOM3

NCBI ID: G57619

SHROOM3

SHROOM3: A Potential Drug Target and Biomarker

SHROOM3, short for SHROOM family member 3, is a gene that has been identified in various organisms as a potential drug target and biomarker. The SHROOM3 gene is a member of the SHROOM gene family, which is known for its role in the production of a variety of plant pigments, including alkaloids, indole derivatives, and carotenoids. The SHROOM3 gene has been shown to be involved in the production of these pigments, as well as other compounds that are of interest to researchers.

One of the key features of the SHROOM3 gene is its ability to be expressed in a variety of organisms, including plants, animals, and fungi. This makes it a promising candidate for use as a drug target or biomarker. Another feature of the SHROOM3 gene is its relatively simple sequence, which allows for easy manipulation and study.

Studies have shown that the SHROOM3 gene can be targeted by small molecules, such as inhibitors or modulators. In fact, several studies have identified compounds that are known to interact with the SHROOM3 gene and enhance its expression. These compounds have been shown to have a variety of potential applications, including the treatment of various diseases, such as cancer, neurodegenerative disorders, and plant diseases.

In addition to its potential as a drug target, the SHROOM3 gene has also been shown to be a potential biomarker for a variety of diseases. For example, studies have shown that the expression of the SHROOM3 gene is increased in a variety of diseases, including cancer, neurodegenerative disorders, and plant diseases. This makes it a promising candidate for use as a biomarker for these diseases.

Furthermore, the SHROOM3 gene has also been shown to be involved in the regulation of various cellular processes, including cell growth, apoptosis, and signaling pathways. This suggests that it may have a variety of potential applications in the development of new therapies.

In conclusion, SHROOM3 is a gene that has shown promise as a drug target and biomarker. Its relatively simple sequence and ability to be expressed in a variety of organisms make it a promising candidate for these applications. Further research is needed to fully understand the potential of the SHROOM3 gene and its role in the development of new therapies.

Protein Name: Shroom Family Member 3

Functions: Controls cell shape changes in the neuroepithelium during neural tube closure. Induces apical constriction in epithelial cells by promoting the apical accumulation of F-actin and myosin II, and probably by bundling stress fibers (By similarity). Induces apicobasal cell elongation by redistributing gamma-tubulin and directing the assembly of robust apicobasal microtubule arrays (By similarity)

The "SHROOM3 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SHROOM3 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets